Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity. Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, we show that recently developed SIRT1 activators, which are effective in improving energy homeostasis and decreasing hepatosteatosis in mouse models (Milne et al. 2007;Feige et al. 2008), also increase ubiquitination and proteasomal targeting of SREBP-1a, resulting in decreased SREBP-1 nuclear levels and target gene expression.”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have reported the identification of potent SIRT1-activating compounds, and showed that such SIRT1 activators could significantly ameliorate insulin resistance and improve energy homeostasis in mouse diet-induced obesity models (Milne et al. 2007).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
In the citing paper
“In contrast to these negative regulators of insulin action, SIRT1 appears to be a positive regulator of insulin sensitivity (43,44).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [43]
In the citing paper
“Additionally, the non-naturally occurring sirtuin-activating compound, SRT1720, has enhanced insulin sensitivity and oxidative metabolism in animal models of obesity, in part, by improving mitochondrial oxidative capacity231.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [231]
In the citing paper
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation (218). These compounds also improve insulin sensitivity in obese rodents (218).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationSirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Self-citation
Research works printed but not linked: 1
- Banks A, et al. Overexpression of the Sirtuin SIRT1 increases insulin sensitivity in aging mice. Diabetes. 2007;56(S1):0234-OR. [Google Scholar]
Cited by
Items 201–300 of 1,004
Sirtuins, Aging, and Metabolism
Guarente, L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010629 · Cited by 202
“These activators include the natural product resveratrol (Howitz et al. 2003) and newer more potent synthetic compounds (Milne et al. 2007).”
BackgroundHenstridge, D. C., Bruce, C. R., Drew, B. G., Tory, K., Kolonics, A., Estevez, E., Chung, J., Watson, N., Gardner, T., Lee-Young, R. S., et al. (2014) · Diabetes · doi:10.2337/db13-0967 · Cited by 201
“Another important fuel-sensing molecule is the NAD-dependent deacetylase SIRT1, an important regulator of oxidative metabolism (12,35).”
BackgroundPTP1B and TCPTP – nonredundant phosphatases in insulin signaling and glucose homeostasis
Tiganis, T. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08563.x · Cited by 200
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Hoshino, J., Park, E.-J., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., Mo, S., Li, Y., & Cushman, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100274c · Cited by 202
“(E)-4-[3,5-bis(tert-Butyldimethylsilyloxy)styryl]phenol (13).”
Wang, F., Tian, X., Zhang, L., He, C., Ji, P., Li, Y., Tan, D., & Liu, G. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.041 · Cited by 202
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases
Whitaker, R. M., Corum, D., Beeson, C. C., & Schnellmann, R. G. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103155 · Cited by 200
The neurobiology of sirtuins and their role in neurodegeneration
Donmez, G. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.05.007 · Cited by 200
Autophagy: Regulation and role in disease
Meijer, A. J., & Codogno, P. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360903044068 · Cited by 199
“Because calorie restriction provides protection against many diseases, including cardiovascular disease, cancer, metabolic syndrome, type-2 diabetes, and neurodegenerative diseases, strategies intended to activate sirtuins may be used to combat these pathologies.(318,321) Sirt1, which increases in starvation, also app…”
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 198
Resveratrol, sirtuins, and the promise of a DR mimetic
Baur, J. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.02.007 · Cited by 196
“…decrease body weight (which occurs at high doses of resveratrol), prevent fatty liver, and improve rotarod performance, providing support for the assertion that SIRT1 mediates salient effects of resveratrol (Bordone et al., 2007; Feige et al., 2008; Milne et al., 2007; Pfluger et al., 2008).”
InfluentialSIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
Manjula, R., Anuja, K., & Alcain, F. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585821 · Cited by 195
“5BTR) and suggested that the stimulatory effect of RSV requires the presence of an N-terminal domain (NTD) and a catalytic domain (CD) of SIRT1 (Hubbard et al., 2013a; Milne et al., 2007), which is similar across all SIRT isoforms.”
BackgroundResveratrol regulates human adipocyte number and function in a Sirt1-dependent manner
Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K.-M., Fulda, S., & Wabitsch, M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28435 · Cited by 195
“Indeed, small molecule activators of Sirt1 have been shown to hold promise for treating type 2 diabetes and other dietinduced metabolic disorders (17, 18).”
BackgroundSelsby, J. T., Morine, K. J., Pendrak, K., Barton, E. R., & Sweeney, H. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030063 · Cited by 195
“Thus, resveratrol mimicked some, but not all, changes associated PGC-1a pathway activation suggesting that either an alternative dose of resveratrol or more potent Sirt-1 activator [39] should be evaluated.”
BackgroundHypothalamic Sirt1 Regulates Food Intake in a Rodent Model System
Çakir, I., Perello, M., Lansari, O., Messier, N. J., Vaslet, C. A., & Nillni, E. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008322 · Cited by 194
“other sirtuin family members [16,17].”
Hwang, J., Sundar, I. K., Yao, H., Sellix, M. T., & Rahman, I. (2014) · The FASEB Journal · doi:10.1096/fj.13-232629 · Cited by 194
“SRT1720 (100 mg/kg, 95% pure by C-13 NMR and LCMS, synthesized by Life Chemicals, Niagara-on-the-Lake, ON, Canada) was administered to the acute air- and CS-exposed mice daily for 3 d through oral gavage 1 h before CS exposure (40).”
MethodSundar, I. K., Yao, H., & Rahman, I. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4863 · Cited by 193
“These findings suggest a role for SIRT1 activators (90, 91) in the therapeutic intervention of COPD.”
BackgroundNAD + metabolism: A therapeutic target for age-related metabolic disease
Mouchiroud, L., Houtkooper, R. H., & Auwerx, J. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.789479 · Cited by 193
“metabolic abnormalities in mice models (Feige et al., 2008; Milne et al., 2007).”
BackgroundSoluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M. P., et al. (2012) · Nature Communications · doi:10.1038/ncomms1781 · Cited by 192
Mammalian Sirtuins and Energy Metabolism
Li, X., & Kazgan, N. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.575 · Cited by 192
“Consistently, treatment of mice on a high fat diet with resveratrol, a polyphenol that activates SIRT1, has been shown to protect against high-fat induced obesity and metabolic derangements (56-58).”
BackgroundPPAR control: it's SIRTainly as easy as PGC
Sugden, M. C., Caton, P. W., & Holness, M. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0359 · Cited by 192
“More recently small molecular weight molecules, including SRT1460 and SRT1720, that selectively activate SIRT1 and are 1000-fold more potent activators than (and structurally unrelated to) resveratrol have been identified (Milne et al. 2007).”
BackgroundInfluentialGlycaemic control in type 2 diabetes: Targets and new therapies
Tahrani, A. A., Piya, M. K., Kennedy, A., & Barnett, A. H. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.001 · Cited by 190
Gano, L. B., Donato, A. J., Pasha, H. M., Hearon, C. M., Sindler, A. L., & Seals, D. R. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00377.2014 · Cited by 185
Yamakuchi, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00068 · Cited by 188
Gao, Z., Zhang, J., Kheterpal, I., Kennedy, N., Davis, R. J., & Ye, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228874 · Cited by 187
Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress
Luo, G., Jian, Z., Zhu, Y., Zhu, Y., Chen, B., Ma, R., Tang, F., & Xiao, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4125 · Cited by 187
Liang, D., Zhuo, Y., Guo, Z., He, L., Wang, X., He, Y., Li, L., & Dai, H. (2020) · Biochimie · doi:10.1016/j.biochi.2019.12.001 · Cited by 182
Csiszar, A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05848.x · Cited by 184
SIRT1 in the brain—connections with aging-associated disorders and lifespan
Ng, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00064 · Cited by 182
“…experiments with transgenic overexpression or pharmacological activation of SIRT1 in mice improved metabolic parameters later in life (Baur et al., 2006; Alcendor et al., 2007; Milne et al., 2007; Herranz et al., 2010), but did not significantly increase lifespan in mice (Herranz et al., 2010).”
BackgroundResveratrol and diabetes: A critical review of clinical studies
Öztürk, E., Arslan, A. K. K., Yerer, M. B., & Bishayee, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.070 · Cited by 184
Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Neuroprotective properties of resveratrol in different neurodegenerative disorders
Albani, D., Polito, L., Signorini, A., & Forloni, G. (2010) · BioFactors · doi:10.1002/biof.118 · Cited by 182
“These compounds, which were discovered as positive modulators of lifespan in Saccharomyces cerevisiae [14], are considered the basis to develop promising therapeutic tools in several diseases including diabetes and metabolic disorders [15,16], cardiovascular diseases [17,18], inflammation [19], and cancer [20–22].”
BackgroundResveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice
Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lu, Q., Oelze, M., Torzewski, M., Lackner, K. J., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168724 · Cited by 181
“Resveratrol is a putative activator of the class III histone deacetylase sirtuin 1 (SIRT1) (Milne et al., 2007), which regulates a variety of cellular functions such as genome maintenance, longevity, and metabolism (Michan and Sinclair, 2007; Milne and Denu, 2008).”
BackgroundErion, D. M., Yonemitsu, S., Nie, Y., Nagai, Y., Gillum, M. P., Hsiao, J. J., Iwasaki, T., Stark, R., Weismann, D., Yu, X. X., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812931106 · Cited by 180
“have shown that SirT1 activators improved whole body insulin sensitivity and liver insulin responsiveness in Zucker fa/fa rats (31).”
BackgroundAkt/PKB: one kinase, many modifications
Risso, G., Blaustein, M., Pozzi, B., Mammi, P., & Srebrow, A. (2015) · Biochemical Journal · doi:10.1042/bj20150041 · Cited by 178
Mao, Z., Tian, X., Van Meter, M., Ke, Z., Gorbunova, V., & Seluanov, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200583109 · Cited by 176
“Other members of the sirtuin gene family have been shown to be amenable to pharmacological stimulation (34, 35), and recent reports have suggested that SIRT6 may be an intriguing candidate for activation to ameliorate the effect of multiple age-related pathologies.”
BackgroundBradford, P. G. (2013) · BioFactors · doi:10.1002/biof.1074 · Cited by 175
“Studies with the polyphenol resveratrol as well as other more potent molecules identified through a novel screening program for SIRT1 activators showed that these dietary SIRT1 activators improved insulin sensitivity of liver, muscle, and fat in genetic and diet-induced obese mice [98].”
BackgroundGracia-Sancho, J., Villarreal, G., Zhang, Y., & Garcia-Cardena, G. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp337 · Cited by 174
“SIRT1 activators are being actively investigated as potential therapeutic agents for diseases of ageing such as type II diabetes and atherosclerosis.(22,23) Indeed, SIRT1 activation has been shown to improve vascular function via an increase in eNOS expression, as well as suppress atherosclerotic lesion formation.”
BackgroundKnutson, M. D., & Leeuwenburgh, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00109.x · Cited by 176
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M., Pezzuto, J. M., Santarsiero, B. D., & Mesecar, A. D. (2010) · Biochemical Journal · doi:10.1042/bj20091857 · Cited by 175
Hausenblas, H. A., Schoulda, J. A., & Smoliga, J. M. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400173 · Cited by 174
Natural polyphenols in cancer therapy
Asensi, M., Ortega, A., Mena, S., Feddi, F., & Estrela, J. M. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.631268 · Cited by 174
Palikaras, K., Daskalaki, I., Markaki, M., & Tavernarakis, N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.04.005 · Cited by 171
“…the precise mechanism of their action is not delineated, SIRT1 activity is triggered upon SRT1720 and SRT2104 supplementation leading to lifespan extension and finetuned mitochondrial function, protecting against diet-induced obesity, similar to resveratrol (Feige et al., 2008; Milne et al., 2007).”
BackgroundAged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
Yang, C., Wang, Z., Li, L., Zhang, Z., Jin, X., Wu, P., Sun, S., Pan, J., Su, K., Jia, F., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002875 · Cited by 172
“The change in the OCR was mainly related to mitochondrial function.”
The Role of Mammalian Sirtuins in the Regulation of Metabolism, Aging, and Longevity
Satoh, A., Stein, L., & Imai, S. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-21631-2_7 · Cited by 172
“Considering the physiological effects of SIRT1 activity, SIRT1 activation has clear potential to combat numerous age-associated diseases, including metabolic syndrome, type 2 diabetes, cardiovascular disease, and neurodegenerative diseases (Borradaile and Pickering 2009; Ginsberg and MacCallum 2009; Hwang et al. 2009;…”
BackgroundInfluentialPaschalaki, K. E., Starke, R. D., Hu, Y., Mercado, N., Margariti, A., Gorgoulis, V. G., Randi, A. M., & Barnes, P. J. (2013) · Stem Cells · doi:10.1002/stem.1488 · Cited by 172
Paths of Convergence: Sirtuins in Aging and Neurodegeneration
Gan, L., & Mucke, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.015 · Cited by 172
“Highly potent and much more specific SIRT1 activators that are structurally unrelated to resveratrol improve whole-body glucose homeostasis and insulin sensitivity in mouse models related to type-2 diabetes (Milne et al., 2007).”
BackgroundGurd, B. J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-070 · Cited by 171
Funk, J. A., & Schnellmann, R. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.026 · Cited by 170
Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function
Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., & Xu, D. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149831 · Cited by 170
Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)
Brisdelli, F., D'Andrea, G., & Bozzi, A. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375423 · Cited by 168
“SIRT1 has been postulated to play a key role in regulating glucose homeostasis [209, 214] and may be implicated in the insulin signaling cascade [215].”
BackgroundResveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis
Fonseca-Kelly, Z., Nassrallah, M., Uribe, J., Khan, R. S., Dine, K., Dutt, M., & Shindler, K. S. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00084 · Cited by 166
Andrade, J. M. O., Frade, A. C. M., Guimarães, J. B., Freitas, K. M., Lopes, M. T. P., Guimarães, A. L. S., de Paula, A. M. B., Coimbra, C. C., & Santos, S. H. S. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0655-6 · Cited by 168
“Activation of NAD-dependent deacetylase SIRT1 by natural compound, calorie restriction or exercise promotes mitochondrial biogenesis and activities [11, 12], raising the possibility that SIRT1 regulates BAT functions.”
BackgroundInvestigating the ADP-ribosyltransferase Activity of Sirtuins with NAD Analogues and 32P-NAD
Du, J., Jiang, H., & Lin, H. (2009) · Biochemistry · doi:10.1021/bi802093g · Cited by 165
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., Doganay, L., & Enc, F. Y. (2011) · Medical Science Monitor · doi:10.12659/msm.881749 · Cited by 165
“Furthermore, small-molecule SIRT1 activators with structures unrelated to resveratrol but with 1000 times the potency have been identified [17].”
BackgroundMolecular determinants of brown adipocyte formation and function: Figure 1.
Farmer, S. R. (2008) · Genes & Development · doi:10.1101/gad.1681308 · Cited by 165
“Such PET scans have located hypermetabolic BAT in the cervical, supraclavicular, paravertebral, mediastinal, para-aortic, and suprarenal regions (but no interscapular) of adult subjects (Nedergaard et al. 2007).”
BackgroundKubota, S., Kurihara, T., Mochimaru, H., Satofuka, S., Noda, K., Ozawa, Y., Oike, Y., Ishida, S., & Tsubota, K. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2666 · Cited by 164
Advances in the Treatment of Type 2 Diabetes Mellitus
Israili, Z. H. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181afbf51 · Cited by 165
Sirtuins and their Biological Relevance in Aging and Age-Related Diseases
Zhao, L., Cao, J., Hu, K., He, X., Yun, D., Tong, T., & Han, L. (2020) · Aging and disease · doi:10.14336/ad.2019.0820 · Cited by 162
Yamazaki, Y., Usui, I., Kanatani, Y., Matsuya, Y., Tsuneyama, K., Fujisaka, S., Bukhari, A., Suzuki, H., Senda, S., Imanishi, S., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90997.2008 · Cited by 137
Ljubicic, V., Miura, P., Burt, M., Boudreault, L., Khogali, S., Lunde, J. A., Renaud, J.-M., & Jasmin, B. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr265 · Cited by 162
Structural Basis for Sirtuin Activity and Inhibition
Yuan, H., & Marmorstein, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.372300 · Cited by 160
Dao, T.-M. A., Waget, A., Klopp, P., Serino, M., Vachoux, C., Pechere, L., Drucker, D. J., Champion, S., Barthélemy, S., Barra, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020700 · Cited by 161
“), peanuts (Arachis spp), berries (Vaccinium sp), and polygonum cuspidatum, that exerts multiple beneficial metabolic actions in vivo [11,12,13].”
BackgroundGomes, A. P., Duarte, F. V., Nunes, P., Hubbard, B. P., Teodoro, J. S., Varela, A. T., Jones, J. G., Sinclair, D. A., Palmeira, C. M., & Rolo, A. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.008 · Cited by 159
“BBR did not directly activate SIRT1 as evaluated with an in vitro activity assay (data not shown), indicating that it likely does not function in the same manner as the commonly used Sirtuin Activating Compounds (STACs) [49].”
Self-citationCalorie restriction mimetics: Can you have your cake and eat it, too?
Ingram, D. K., & Roth, G. S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.11.005 · Cited by 161
Necdin Regulates p53 Acetylation via Sirtuin1 to Modulate DNA Damage Response in Cortical Neurons
Hasegawa, K., & Yoshikawa, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3052-08.2008 · Cited by 162
“RSV is suggested to act on Sirt1 at an allosteric site N terminal to the catalytic domain (sirtuin homology domain) (amino acids 183–225) (Milne et al., 2007).”
BackgroundNovel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
“[217] Melatonin C13H16N2O2 232.282 chronic stress mice Female BALB/c mice 20 mg/kg/day, intraperitoneal injection, 28 days Melatonin alleviates chronic stress-induced oxidative meiosis defects in mouse MII oocytes by regulating SIRT1 and autophagy [61] SRT1720 C25H24ClN7OS 506.02236 Type 2 diabetic mice Male C57BL/KsJ…”
InfluentialMai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008289 · Cited by 156
SIRT1 Deacetylase in SF1 Neurons Protects against Metabolic Imbalance
Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michán, S., Vianna, C. R., Sinclair, D. A., Elias, C. F., & Coppari, R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.014 · Cited by 158
“On the other hand, the protective mechanism(s) against dietary T2DM is unknown.”
BackgroundInfluentialSelf-citationGLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1
Xu, F., Lin, B., Zheng, X., Chen, Z., Cao, H., Xu, H., Liang, H., & Weng, J. (2016) · Diabetologia · doi:10.1007/s00125-016-3896-5 · Cited by 157
FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
Oellerich, M. F., & Potente, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246488 · Cited by 157
SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer
Kabra, N., Li, Z., Chen, L., Li, B., Zhang, X., Wang, C., Yeatman, T., Coppola, D., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000034 · Cited by 157
Mitochondrial Dynamics and Mitochondrial Dysfunction in Diabetes.
Wada, J., & Nakatsuka, A. (2016) · PubMed · doi:10.18926/amo/54413 · Cited by 156
Zhou, Y., Wang, S., Li, Y., Yu, S., & Zhao, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00443 · Cited by 157
“SRT1720 was produced as described previously (Milne et al., 2007; Funk et al., 2010).”
MethodZhang, B., Zhai, M., Li, B., Liu, Z., Li, K., Jiang, L., Zhang, M., Yi, W., Yang, J. Z., Yi, D., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3159801 · Cited by 160
“SIRT1, the most studied mammalian sirtuin, has been extensively investigated to produce beneficial effects on glucose homeostasis and cardiovascular functions [16, 48, 49].”
BackgroundAging by epigenetics—A consequence of chromatin damage?
Sedivy, J. M., Gowrishankar, B., & Adams, P. D. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.023 · Cited by 170
“Remarkably, addition of a SirT1 activator, resveratrol, to the diet of mice fed a high fat diet prolongs the healthy lifespan of those mice [114,115], apparently mimicking the well-established contribution of dietary caloric restriction Sedivy et al.”
BackgroundGoto, M. (2008) · PubMed · Cited by 182
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 176
Yu, J., & Auwerx, J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.006 · Cited by 154
“The administration of a more specific and potent synthetic SIRT1 activator, SRT1720, leads to similar protective effects on metabolism in mice [30,31].”
BackgroundThe Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154
“To directly assess the insulin-sensitizing effect of SIRT1, numerous small molecule activators of this sirtuin have been identified and studied (255, 256).”
BackgroundJin, L., Galonek, H., Israelian, K., Choy, W., Morrison, M., Xia, Y., Wang, X., Xu, Y., Yang, Y., Smith, J. J., et al. (2009) · Protein Science · doi:10.1002/pro.50 · Cited by 151
“SRT1720 has previously been shown to activate SIRT1.”
BackgroundMethodInfluentialSelf-citationCao, Y., Jiang, X., Ma, H., Wang, Y., Xue, P., & Liu, Y. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.022 · Cited by 170
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
Sajish, M., & Schimmel, P. (2015) · Nature · doi:10.1038/nature14028 · Cited by 151
“g, Only the full-length TyrRS (1-528) and none of the various fragments of TyrRS (mini-TyrRS (1-364), ΔN-TyrRS (228-528) or the C-domain (328-528)) interacts with PARP-1.”
BackgroundFunk, J. A., Odejinmi, S. I., & Schnellmann, R. G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161992 · Cited by 161
Khalili, L., Department of Nutrition, F. O. N. A. F. S., Alipour, B., Department of Community Nutrition, F. O. N. A. F. S., Asghari Jafar-Abadi, M., Department of statistics and Epidemiology, F. O. H., Faraji, I., Internist, F. O. E., Hassanalilou, T., Department of Nutrition, F. O. N. A. F. S., et al. (2019) · Iranian Biomedical Journal · doi:10.29252/ibj.23.1.68 · Cited by 151
Mitochondrial function as a determinant of life span
Lanza, I. R., & Nair, K. S. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0724-5 · Cited by 152
“These compounds have also been shown to reduce dietinduced obesity and insulin resistance and to increase mitochondria activity in a rodent model [141, 143, 146].”
BackgroundSirtuin 1 (SIRT1): The Misunderstood HDAC
Stünkel, W., & Campbell, R. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422103 · Cited by 164
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
Komen, J. C., & Thorburn, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12413 · Cited by 149
“The low bioavailability has resulted in the development of more potent small activators of sirtuins, also known as sirtuin-activating compounds, which may cause fewer off-target effects (Milne et al., 2007; Feige et al., 2008).”
BackgroundIyer, S. V., Han, L., Bartell, S. M., Kim, H., Gubrij, I. B., de Cabo, R., O’Brien, C. A., Manolagas, S. C., & Almeida, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561803 · Cited by 156
“To further examine the actions of Sirt1 on osteoblastogenesis, we used SRT2104, a synthetic small molecule activator of Sirt1 (24).”
MethodTesta, G., Biasi, F., Poli, G., & Chiarpotto, E. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660699 · Cited by 148
“SRT1720, SRT1460, and SRT2183 [392, 262].”
BackgroundBiological and Medicinal Properties of Grapes and Their Bioactive Constituents: An Update
Yadav, M. K., Jain, S., Bhardwaj, A., Nagpal, R., Puniya, M., Tomar, R., Singh, V., Parkash, O., Prasad, G. B. K. S., Marotta, F., et al. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0096 · Cited by 148
“53 Resveratrol is also known to interact with numerous proteins and pathways involved in pathogenesis of obesity, including mitochondrial ATP synthase and complex III, fatty acid synthase, protein kinase C, p53, mitogen-activated protein kinase kinase1, TNF-a , and NF-k B, all of which are…”
Koo, J., Kang, E., Oh, Y.-S., Yang, D.-S., & Cho, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.014 · Cited by 165
“Sirtuin-1 (SIRT-1), a member of the sirtuin family, plays an essential role in regulating cellular homeostasis by influencing neuron survival, insulin sensitivity, glucose metabolism, and mitochondrial biogenesis (Lagouge et al., 2006; Milne et al., 2007; Guarente, 2013).”
Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 163
Biological and Potential Therapeutic Roles of Sirtuin Deacetylases
Taylor, D. M., Maxwell, M. M., Luthi‐Carter, R., & Kazantsev, A. G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8357-y · Cited by 159
Biochemical effects of SIRT1 activators
Baur, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.025 · Cited by 145
“Recently, a more potent synthetic SIRT1 activator that is structurally unrelated to resveratrol was described and designated SRT1720 (Figure 3) [110].”
BackgroundLibri, V., Brown, A. P., Gambarota, G., Haddad, J., Shields, G. S., Dawes, H., Pinato, D. J., Hoffman, E., Elliot, P. J., Vlasuk, G. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051395 · Cited by 135
“metabolic pathways, including glucose metabolism [5], fatty acid oxidation [6], regulation of oxidative stress [7], lipid metabolism and fat mobilization in white adipocytes [8,9], as well as improved”
Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging
Sarubbo, F., Esteban, S., Miralles, A., & Moranta, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170703113212 · Cited by 153
“This is very important in the brain since it has been shown that SIRT1 regulate energy metabolism, axonal growth, dendrite formation, neuronal plasticity, neuronal survival against stress, and suppress inflammation by NF-κB modulation [18, 92, 174], as has been pointed out in models of chronic inflammatory diseases [1…”
BackgroundPrevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
Lee, S.-M., Yang, H., Tartar, D. M., Gao, B., Luo, X., Ye, S. Q., Zaghouani, H., & Fang, D. (2011) · Diabetologia · doi:10.1007/s00125-011-2064-1 · Cited by 142
“Resveratrol (trans-3,4′,5-trihydroxystilbene), a compound of the polyphenol group that is found in various fruits and vegetables, and is abundant in grapes [1], has recently emerged as a potential therapeutic reagent for many diseases, such as type 2 diabetes [2], cardiovascular heart diseases [3], cancers [4] and dis…”
BackgroundSelf-citationSirtuins and Insulin Resistance
Zhou, S., Tang, X., & Chen, H.-Z. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00748 · Cited by 142
“For instance, the SIRT1 activator SRT1720 extends lifespan and improves the health of mice fed a standard diet (163, 256).”
BackgroundWallace, D. C. (2008) · Genetics · doi:10.1534/genetics.104.91769 · Cited by 140
A continuous microplate assay for sirtuins and nicotinamide-producing enzymes
Smith, B. C., Hallows, W. C., & Denu, J. M. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.07.019 · Cited by 137
“Although several other sirtuin high-throughput screens have been reported [8,12,14,19,36], the coupled assay could be adapted to a high-throughput format.”
Background
Metadata
- Authors
- Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., & Westphal, C. H.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Westphal, Christoph H.
- ORCID
- Venue
- Nature
- Published
- 2007-11-29
- Volume
- 450
- Issue
- 7170
- Pages
- 712-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2753457
- OpenAlex
- W2116350182
- Cited by
- 1,707
- References
- 27
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 55 · 2023: 55 · 2022: 68 · 2021: 100 · 2020: 80 · 2019: 75 · 2018: 82 · 2017: 69 · 2016: 92 · 2015: 89 · 2014: 110 · 2013: 119 · 2012: 126
- FWCI
- 55.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (P01AG027916, R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- SIRT1, small molecule activators, type 2 diabetes, insulin resistance, caloric restriction mimetics, resveratrol, NAD+-dependent deacetylase, allosteric site, glucose homeostasis, mitochondrial function, obesity, aging, drug screening
- MeSH terms
- Resveratrol, Acetylation, Allosteric Site, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Type 2, Dietary Fats, Disease Models, Animal, Drosophila melanogaster, Heterocyclic Compounds, 4 or More Rings, Humans, Insulin, Male, Mitochondria, Rats, Zucker, Stilbenes, Rats, Sprague-Dawley, Catalytic Domain, Caloric Restriction, Sirtuins, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.